92 related articles for article (PubMed ID: 3720699)
1. Pharmacokinetics of R-enantiomeric normephenytoin during chronic administration in epileptic patients.
Bourgeois BF; Küpfer A; Wad N; Egli M
Epilepsia; 1986; 27(4):412-8. PubMed ID: 3720699
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective metabolism and pharmacogenetic control of 5-phenyl-5-ethylhydantoin (nirvanol) in humans.
Küpfer A; Patwardhan R; Ward S; Schenker S; Preisig R; Branch RA
J Pharmacol Exp Ther; 1984 Jul; 230(1):28-33. PubMed ID: 6747829
[TBL] [Abstract][Full Text] [Related]
3. Mephenytoin hydroxylation deficiency: kinetics after repeated doses.
Küpfer A; Desmond P; Patwardhan R; Schenker S; Branch RA
Clin Pharmacol Ther; 1984 Jan; 35(1):33-9. PubMed ID: 6690169
[TBL] [Abstract][Full Text] [Related]
4. Direct enantiomeric resolution of mephenytoin and its N-demethylated metabolite in plasma and blood using chiral capillary gas chromatography.
Wedlund PJ; Sweetman BJ; McAllister CB; Branch RA; Wilkinson GR
J Chromatogr; 1984 Apr; 307(1):121-7. PubMed ID: 6725478
[TBL] [Abstract][Full Text] [Related]
5. Disposition of mephenytoin and its metabolite, nirvanol, in epileptic patients.
Theodore WH; Newmark ME; Desai BT; Kupferberg HJ; Penry JK; Porter RJ; Yonekawa WD
Neurology; 1984 Aug; 34(8):1100-2. PubMed ID: 6431315
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic differences in mephenytoin pharmacokinetics in normal subjects.
Wedlund PJ; Aslanian WS; Jacqz E; McAllister CB; Branch RA; Wilkinson GR
J Pharmacol Exp Ther; 1985 Sep; 234(3):662-9. PubMed ID: 4032286
[TBL] [Abstract][Full Text] [Related]
7. Relation of in vivo drug metabolism to stereoselective fetal hydantoin toxicology in mouse: evaluation of mephenytoin and its metabolite, nirvanol.
Wells PG; Küpfer A; Lawson JA; Harbison RD
J Pharmacol Exp Ther; 1982 Apr; 221(1):228-34. PubMed ID: 7062285
[TBL] [Abstract][Full Text] [Related]
8. Stereoselectivity of the arene epoxide pathway of mephenytoin hydroxylation in man.
Küpfer A; Lawson J; Branch RA
Epilepsia; 1984 Feb; 25(1):1-7. PubMed ID: 6420144
[TBL] [Abstract][Full Text] [Related]
9. Stereoselective metabolism, pharmacokinetics and biliary elimination of phenylethylhydantoin (Nirvanol) in the dog.
Küpfer A; Bircher J; Preisig R
J Pharmacol Exp Ther; 1977 Dec; 203(3):493-9. PubMed ID: 925954
[TBL] [Abstract][Full Text] [Related]
10. Assay of mephenytoin metabolism in human liver microsomes by high-performance liquid chromatography.
Meier UT; Kronbach T; Meyer UA
Anal Biochem; 1985 Dec; 151(2):286-91. PubMed ID: 4096368
[TBL] [Abstract][Full Text] [Related]
11. Mephenytoin: a reappraisal.
Troupin AS; Ojemann LM; Dodrill CB
Epilepsia; 1976 Dec; 17(4):403-14. PubMed ID: 1001284
[TBL] [Abstract][Full Text] [Related]
12. Measurement of mephenytoin (3-methyl-5-ethyl-5-phenylhydantoin) and its demethylated metabolite by selective ion monitoring.
Yonekawa W; Kupferberg HJ
J Chromatogr; 1979 Jun; 163(2):161-7. PubMed ID: 541367
[TBL] [Abstract][Full Text] [Related]
13. Stereoselective mephobarbital hydroxylation cosegregates with mephenytoin hydroxylation.
Küpfer A; Branch RA
Clin Pharmacol Ther; 1985 Oct; 38(4):414-8. PubMed ID: 4042524
[TBL] [Abstract][Full Text] [Related]
14. Polymorphic metabolism of mephenytoin in man: pharmacokinetic interaction with a co-regulated substrate, mephobarbital.
Jacqz E; Hall SD; Branch RA; Wilkinson GR
Clin Pharmacol Ther; 1986 Jun; 39(6):646-53. PubMed ID: 3709029
[TBL] [Abstract][Full Text] [Related]
15. A major pathway of mephenytoin metabolism in man. Aromatic hydroxylation to p-hydroxymephenytoin.
Küpfer A; Brilis GM; Watson JT; Harris TM
Drug Metab Dispos; 1980; 8(1):1-4. PubMed ID: 6102023
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man.
Küpfer A; Preisig R
Eur J Clin Pharmacol; 1984; 26(6):753-9. PubMed ID: 6489416
[TBL] [Abstract][Full Text] [Related]
17. Stereochemistry of aromatic phenytoin hydroxylation in various drug hydroxylation phenotypes in humans.
Fritz S; Lindner W; Roots I; Frey BM; Küpfer A
J Pharmacol Exp Ther; 1987 May; 241(2):615-22. PubMed ID: 3572817
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacology of mephenytoin and ethotoin.
Troupin AS; Friel P; Lovely MP; Wilensky AJ
Ann Neurol; 1979 Nov; 6(5):410-4. PubMed ID: 42344
[TBL] [Abstract][Full Text] [Related]
19. Enantiospecific separation and quantitation of mephenytoin and its metabolites nirvanol and 4'-hydroxymephenytoin in human plasma and urine by liquid chromatography/tandem mass spectrometry.
Jansson B; Elsherbiny D; Simonsson US
Rapid Commun Mass Spectrom; 2006; 20(3):463-72. PubMed ID: 16395737
[TBL] [Abstract][Full Text] [Related]
20. Stereochemical aspects of the metabolism of 5-ethyl-5-phenylhydantoin (Nirvanol) in the dog.
Maguire JH; Kraus BL; Butler TC; Dudley KH
Drug Metab Dispos; 1981; 9(5):393-401. PubMed ID: 6117436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
